The Importance of Clinical Trials to Treat Blood Cancer (Nurse)

Credit Available: CME,NCPD

 

Enroll in this Course

FREE

access until May 6, 2025 12:00 am

 

Enroll Now

Activity Description

The Leukemia & Lymphoma Society created the Clinical Trial Support Center (CTSC), a free clinical trial nurse navigation service for blood cancer patients, their families and healthcare providers. The CTSC is a team of nurse navigators, with expertise in pediatric and adult hematology/oncology, who work one-on-one with patients, their caregivers or healthcare providers. A dedicated nurse navigator completes comprehensive nursing, educational and psychosocial assessments to understand a patient’s diagnosis and treatment history, their understanding of available treatment options and clinical trials, and goals of care and support resources available to participate in a clinical trial. Taking this information into consideration, the nurse navigator completes an unbiased search, providing an individualized list of potential clinical trials and educational resources. The nurse navigator may also contact principal investigators, study coordinators and sponsors to inquire about a patient’s eligibility, referral process and waitlist, travel assistance and other financial resources. The goal of the CTSC is not for every patient to enroll into a clinical trial, but to increase awareness of clinical trials as a treatment option, facilitate informed decision-making between a patient and their healthcare team, and to minimize the barriers to enrollment if a patient decides that a clinical trial is right for them.

The unique relationship between a patient and their nurse navigator plays a pivotal role in overcoming many barriers to clinical trial enrollment. CTSC nurse navigators work in conjunction with healthcare providers, offloading the time-consuming work of identifying potential clinical trials and clinical trial outreach, and emphasizing the importance of shared decision-making.

Time to Complete Activity: 0.5 hours

This course is available from:

November 7, 2023 until May 6, 2025

Course Instructors

Kelly Laschinger, MSN, RN, CPNP, CPHON Speaker

Manager, Clinical Trial Support Center, The Leukemia & Lymphoma Society Rye , NY

Steven Tsai, MD, PhD Speaker

Hematologist, UCLA Health Cancer Care,  Los Angels, CA

Target Audience

This activity is intended for oncologists and hematologists, advanced practice providers, and nurses involved in the care of patients in community and academic practices.

Educational Objectives

After completing this activity, the participant should be better able to:

• • Summarize the basics of clinical trials
  • Explain the development and phases of clinical trials
  • Describe disparities in clinical trials
  • Engage patients and caregivers in discussion on risks, benefits, myths and costs of clinical trials
  • Explain how LLS can help locate clinical trials that may be right for your patients

Accreditation, Support and Credit

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and The Leukemia & Lymphoma Society.  Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Medical Learning Institute, Inc. (MLI) designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

Successful completion of this nursing continuing professional development activity will be awarded 0.5 contact hour and no contact hour in the area of pharmacology.

Interprofessional Continuing Education (IPCE) Statement

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Support Statement

There is no commercial support associated with this CE activity.

Providers 

This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc. in collaboration with The Association of Community Cancer Centers.

Disclosure of Conflicts of Interest Policy

Medical Learning Institute, Inc., is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures

Kelly Laschinger MSN, RN, CPNP, CPHON, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Steven C. Tsai, MD, PhD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

Planner
Lauren Berger, MPH
The Leukemia & Lymphoma Society

Lauren Berger, MPH, has a financial interest/relationship or affiliation in the form of:

Stock Ownership with Bristol Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc., Organon & Co., Pfizer Inc., and Viatris Inc.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the accredited CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute, Inc.

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

If you have questions regarding your certificate, please contact Mary Vu via email at mvu@mlieducation.org

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.

About this Activity

Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.

Copyright © 2023 Medical Learning Institute, Inc. All Rights Reserved.